s.salehpour medical director...
TRANSCRIPT
![Page 1: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/1.jpg)
![Page 2: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/2.jpg)
S.Salehpour
Professor Ob/gyn
Infertility fellowship
Medical director
Gyn ward and IVF center
Taleghani hospital
SBMU
Tehran_ Iran
![Page 3: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/3.jpg)
![Page 4: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/4.jpg)
![Page 5: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/5.jpg)
![Page 6: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/6.jpg)
![Page 7: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/7.jpg)
![Page 8: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/8.jpg)
• Personilized medicine is important in the treatment of pain
![Page 9: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/9.jpg)
• Future medication:
local neurogenesis
central sensitization
genetics
![Page 11: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/11.jpg)
![Page 12: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/12.jpg)
• 11%-%19 no reduction of pain
• 5%-59% pain remaining
• 17%-34% recurrence of pain after stop of therapy
• 5%-16% discontinuation because of adverse effect
• CONCLUSION: Limited or intermittent benefit for medical therapy of endometriosis pain
![Page 13: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/13.jpg)
![Page 15: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/15.jpg)
![Page 16: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/16.jpg)
• GnRh or laparoscopic excision or ?ablation?
Increased pregnancy rate
![Page 17: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/17.jpg)
![Page 18: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/18.jpg)
• Lower oocyte number, lower quality, lower fertilization
![Page 19: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/19.jpg)
• GnRh (3 months) before IVF , low evidence
• Depo progesterones ↑PR before IVF
![Page 20: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/20.jpg)
![Page 21: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/21.jpg)
Ovarian cystectomy
no improvement of ART outcome
![Page 23: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/23.jpg)
![Page 24: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/24.jpg)
![Page 25: S.Salehpour Medical director SBMUgynecology.sbmu.ac.ir/uploads/medical_treatment_endometriosi.pdf · Schematic representation of the different experimental treatments for endometriosis](https://reader030.vdocument.in/reader030/viewer/2022041015/5ec66f74d928bd5f6e0d424e/html5/thumbnails/25.jpg)